NVG-222: A First-in-Class Autoregulating Half-Life Extended ROR1xCD3 T Cell Engager Heralding a New Class of Safer DrugsDavid Granger,Vincent Muczynski,Patricia Henne,Annalisa Baccaro,Dinusha Fernando,Mittal Shah, John Devlin,Kieran O'Donovan,Amit C. NathwaniBLOOD（2023）引用 0|浏览25关键词T Cell Therapy,CAR T Cells,Tumor RegressionAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
